On January 31, 2024, the company announced an increase in its equity buyback plan. The company increased its authorization by CNY 45 million, thereby bringing total authorization to CNY 60 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.47 CNY | +0.24% | -0.70% | -32.02% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.02% | 253M | |
+7.04% | 73.13B | |
+31.10% | 10.38B | |
+37.94% | 5.16B | |
-17.33% | 4.73B | |
+21.49% | 3.81B | |
+24.92% | 2.26B | |
-36.84% | 1.88B | |
-43.31% | 1.77B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.